NiQuitin CQ 14 mg/24 h transdermalni naljepak
| Name | NiQuitin CQ 14 mg/24 h transdermalni naljepak |
|---|---|
| Marketing Authorisation Number | HR-H-297268725 |
| Active Substance | nikotin |
| Composition | jedan transdermalni naljepak veličine 15 cm² sadrži 78 mg nikotina, što odgovara 5,1 mg/cm² nikotina i oslobađanju od 14 mg tijekom 24 sata |
| Pharmaceutical Form | transdermalni naljepak |
| Manufacturer | GlaxoSmithKline Dungarvan Ltd., County Waterford, Irska
Famar A.V.E. , Avlona Attiki, Grčka |
| Marketing Authorisation Holder | Adriatic BST d.o.o., Verovškova ulica 55, Ljubljana, Slovenija |
| Marketing Authorisation Date | 21.11.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/02 |
| Registration Number | 381-12-01/70-18-05 |
| Prescription | bez recepta |
| Distribution | u ljekarni i specijaliziranim prodavaonicama za promet na malo lijekovima |
| Advertising to general public | dopušteno |
| ATC Code | N07BA01 |
| Medicinal product marketed in the Croatia | Trajni prekid opskrbe |
| SmPC | download |
| PL | download |
